What's new

Human medicines European public assessment report (EPAR): Xgeva, denosumab, Date of authorisation: 13/07/2011, Revision: 26, Status: Authorised

Human medicines European public assessment report (EPAR): Xgeva, denosumab, Date of authorisation: 13/07/2011, Revision: 26, Status: Authorised

Mar 13, 2025 - 11:47
 0
Human medicines European public assessment report (EPAR): Xgeva, denosumab, Date of authorisation: 13/07/2011, Revision: 26, Status: Authorised
Human medicines European public assessment report (EPAR): Xgeva, denosumab, Date of authorisation: 13/07/2011, Revision: 26, Status: Authorised
Read More

Tags:

Previous Article

Renault Megane E-Tech expanded with new trim level

Next Article

Hugo Boss Sees Broadly Stable 2025 Sales, Flags Muted Demand in First Quarter

Related Posts

Human medicines European public assessment report (EPAR): Skytrofa (previously Lonapegsomatropin Ascendis Pharma), lonapegsomatropin, Date of authorisation: 11/01/2022, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 12, 2025  0

Human medicines European public assessment report (EPAR): Ulunar Breezhaler, indacaterol,glycopyrronium bromide, Date of authorisation: 23/04/2014, Revision: 15, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 17, 2025  0

Human medicines European public assessment report (EPAR): Wainzua, eplontersen, Date of authorisation: 06/03/2025, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 12, 2025  0